EpiVax Awarded Grant For Vaccine Engineering

$5.8 MILLION AWARDED FOR VACCINE ENGINEERING WILL USE “IMMUNE HISTORY” TO PROTECT AGAINST BIRD FLU, A COLLABORATION LED BY EPIVAX   PROVIDENCE, R.I., Sept. 18, 2017– EpiVax, Inc. (“EpiVax”) a pioneer in the fields of bioinformatics and immune engineering, today...
Westin Seminar 2017 (Tokyo)

Westin Seminar 2017 (Tokyo)

Register Here The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates and network with potential collaborators.  The purpose of this seminar is to bridge the gap between protein drug...